<DOC>
	<DOCNO>NCT00913705</DOCNO>
	<brief_summary>Open-label multicenter randomize Phase III trial .</brief_summary>
	<brief_title>Neoadjuvant Adjuvant Chemotherapy Patients With Operable Non-small-cell Lung Cancer</brief_title>
	<detailed_description>Randomized trial surgery without Paclitaxel ( taxol ) plus Carboplatin neoadjuvant adjuvant chemotherapy patient operable , non-small-cell lung cancer .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>The patient eligible study diagnosis , histologically cytologically proven , NSCLC without metastasis stage IB , IIA , IIB IIIA ( N2 ) disease . Patients stage IA tumor size &gt; 2cm eligible well . Patients age &gt; 18 year . Tumor consider resectable attend surgeon . The patient must ECOG *2 Karnofsky &gt; 60 % . The patient need adequate hematological , renal hepatic function define : Absolute neutrophil count ( ANC* ) *1.5 x 109/L Platelet count *100 x 109/L Total bilirubin *1.25 x upper limit normal distribution Serum creatinine &lt; 120 umol/L ( &lt; 1.5 mg/dl ) Creatinine clearance &gt; 60 ml/min ANC = segment neutrophil + band neutrophils The patient recover serious surgical sequellae . Informed consent must obtain patient accordance requirement IRB/EC . If female , patient must pregnant breastfeeding . Women child bear potential need pregnancy test perform take appropriate contraceptive action period study . Operability criterion : Lung function test perform confirm predictive postoperative value FEV1 &gt; 800 ml , i.e . correct homeostasis . A carbon monoxide diffusion test conduct , applicable , repeat follow induction treatment take account sensitivity postchemotherapy pulmonary toxicity detection . Patients previously treat chemotherapy and/or radiotherapy . History significant cardiovascular disease noncontrolled hypertension , unstable angina congestive heart failure even control medication . Documented history acute myocardial infarction previous year , ventricular arrhythmia require medication 2nd 3rd atrialventricular block . Preexisting sensory motor neurotoxicity grade &gt; 2 base WHO criterion . Active infection clinical state could seriously reduce patient 's capacity tolerate treatment protocol , include previous allergic reaction product contain Cremophor ( e.g . cyclosporin vitamin K ) . Previous concomitant malignant tumor ( exception situ cervical carcinoma , basocellular carcinoma , squamous cell skin carcinoma urothelial superficial carcinoma ) consider potentially curable oncological treatment disease free survival ( DFS ) great 5 year EXCEPTING breast cancer , melanoma hypernephroma Marked psychoses senility</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>NATCH</keyword>
	<keyword>LUNG</keyword>
	<keyword>OPERABLE NSCLC</keyword>
	<keyword>SURGERY PLUS ADJUVANT THERAPY</keyword>
	<keyword>SURGERY PLUS NEOADJUVANT THERAPY</keyword>
</DOC>